E. Ohman J:or Asset Management 13F: Cuts RDNT Stake by $3.8M

E. Ohman J:or Asset Management reduced its holdings in RadNet, Inc. (NasdaqGM:RDNT) by 55,110 shares during the quarter, according to a Form 13F filing made public on October 22, 2026.

RDNT RadNet, Inc.

$69.57 ▼ -1.95% year to date

1M 3M YTD

Daily close · Oct 22, 2026

What Changed in E. Ohman J:or Asset Management's RadNet Position

The fund cut its position by 12.2%, lowering its total ownership to 397,856 shares. The remaining stake carried a reported value of $27,428,193 at the time of the filing. In the previous quarter, the firm held 452,966 shares.

Other Institutional Activity in RadNet

Other large investors adjusted their positions in the medical imaging firm around the same timeframe. RTW Investments LP boosted its holdings by 561,786 shares to end with 4,846,958 shares worth $336,330,412. Beck, Mack & Oliver LLC trimmed its stake by 2,533 shares, leaving it with 3,163,592 shares valued at $219,521,646. American Century Companies Inc significantly expanded its holdings, adding 716,242 shares to own 1,618,424 shares worth $112,302,440.

RadNet, Inc. Stock Up 1.2%

RadNet shares recently traded around $69.24 as of October 22, 2026, down slightly from an event close of $69.39. The stock has experienced a wide 52-week trading range, moving between a low of $50.82 and a high of $85.84. The current price sits below the 50-day moving average of $73.12, while holding above the 200-day moving average of $65.29. The company's next earnings report is scheduled for November 5, 2026.

Recent Earnings

RadNet generated $2.27 billion in trailing twelve-month revenue, alongside year-over-year revenue growth of 25.0%. The provider of outpatient diagnostic imaging services reported negative basic earnings per share of $0.27 over the same period, alongside a net profit margin of -0.9% and a return on equity of 1.5%.

Insider Buying and Selling at RadNet, Inc.

Company insiders executed several transactions prior to the filing. Officer Stephen M Forthuber sold 44,067 shares valued at $2,562,911 on June 15, 2026. CEO Howard Berger disposed of 90 shares on June 16, 2026. President Cornelis Wesdorp sold 4,750 shares at $58.11 each for a total of $276,022 on June 16, 2026. Director David L Swartz sold 2,699 shares at $53.89 each for $145,449 on June 18, 2026.

Analysts Set New Price Targets

Wall Street firms updated their views on the healthcare stock leading up to the fall. On August 11, 2026, Truist Securities maintained its Buy rating while raising its price target to $94.00 from $90.00. Later, on August 28, 2026, Barclays kept an Overweight rating on the shares and lifted its target to $79.00 from $65.00. Across the broader analyst community, the stock holds a consensus recommendation alongside a mean price target of $94.63 based on 8 analyst opinions.

About RadNet

RadNet operates outpatient diagnostic imaging centers across the United States. The company provides a wide range of scanning and testing services, including magnetic resonance imaging, computed tomography, mammography, and ultrasound, through its imaging centers and digital health segments.

Bottom Line

Investors will look toward the upcoming November 5 earnings report for fresh details on RadNet's revenue trends and operational margins. Institutional shifts and insider transaction patterns will continue to draw close attention from market participants tracking the healthcare provider's growth trajectory.